A detailed history of Salem Investment Counselors Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Salem Investment Counselors Inc holds 259 shares of VRTX stock, worth $130,134. This represents 0.0% of its overall portfolio holdings.

Number of Shares
259
Previous 259 -0.0%
Holding current value
$130,134
Previous $121,000 0.83%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

BUY
$392.81 - $485.53 $392 - $485
1 Added 0.39%
259 $121,000
Q4 2023

Jan 16, 2024

SELL
$343.0 - $410.68 $686 - $821
-2 Reduced 0.77%
258 $104,000
Q3 2023

Oct 04, 2023

BUY
$338.18 - $362.46 $676 - $724
2 Added 0.78%
260 $90,000
Q1 2023

May 11, 2023

BUY
$283.23 - $323.1 $16,427 - $18,739
58 Added 29.0%
258 $81,000
Q3 2022

Nov 09, 2022

BUY
$273.83 - $305.53 $54,766 - $61,105
200 New
200 $58,000
Q1 2022

May 16, 2022

SELL
$221.42 - $260.97 $412,062 - $485,665
-1,861 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$177.01 - $223.45 $3,894 - $4,915
22 Added 1.2%
1,861 $409,000
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $362 - $405
-2 Reduced 0.11%
1,839 $334,000
Q2 2021

Aug 17, 2021

BUY
$187.49 - $221.1 $344,794 - $406,602
1,839 Added 91950.0%
1,841 $371,000
Q1 2021

May 17, 2021

SELL
$207.02 - $241.31 $3,519 - $4,102
-17 Reduced 89.47%
2 $0
Q4 2020

Feb 17, 2021

BUY
$207.01 - $276.09 $3,933 - $5,245
19 New
19 $4,000
Q3 2019

Nov 13, 2019

SELL
$166.23 - $187.09 $34,742 - $39,101
-209 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$164.61 - $190.37 $278,190 - $321,725
-1,690 Reduced 88.99%
209 $38,000
Q1 2019

May 15, 2019

BUY
$163.73 - $194.7 $818 - $973
5 Added 0.26%
1,899 $366,000
Q4 2018

Feb 15, 2019

SELL
$151.91 - $192.21 $759 - $961
-5 Reduced 0.26%
1,894 $314,000
Q3 2018

Nov 14, 2018

SELL
$167.73 - $192.74 $39,416 - $45,293
-235 Reduced 11.01%
1,899 $366,000
Q4 2017

Feb 16, 2018

BUY
$137.28 - $155.55 $6,864 - $7,777
50 Added 2.4%
2,134 $320,000
Q3 2017

Nov 16, 2017

BUY
$148.13 - $162.24 $308,702 - $338,108
2,084
2,084 $316,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Salem Investment Counselors Inc Portfolio

Follow Salem Investment Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Investment Counselors Inc with notifications on news.